[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"endovascular-procedures\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:endovascular-procedures":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,40,78,103,135,161],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100621593","sensorised-surgical-gloves-for-neuroendovascular-procedures-100621593",false,"NCT07372638","Sensorised Surgical Gloves for Neuroendovascular Procedures","Sensorised Surgical Gloves for Neuroendovascular Procedures: Preclinical Study in Flow Diverter Placement Using 3D Printed Biorealistic Haptic Simulators","Inclusion Criteria:\n\n\\- Experienced neurointerventionist or doctor in training.\n\nExclusion Criteria:\n\n\\- No training in use of medical ionising radiation.","ALL",{"count":18,"type":19},12,"ESTIMATED","INTERVENTIONAL",[22],"NA","A deeper understanding of the forces required for optimal flow diverter stent deployment could improve procedural safety and shorten the learning curve for new devices. In the past, force sensors have been physically attached to devices in some way. The investigators approach is to incorporate force sensors into the hands of the operator handling the device using sensorised surgical gloves. Participants will be asked to deploy a Flow Diverter (FD) in a biorealistic silicone model while wearing force sensing surgical gloves. The primary objective of the study is to show whether sensorised gloves are capable of meaningful force detection in neurointerventional procedures. The investigators will also explore the potential of developing computer vision technology in neurointervention. The investigators are inviting groups of experts and novices to participate. This will allow the investigators to understand if analysis of glove force outputs can distinguish operator experience.",[25,26],"Endovascular Procedures","Force Sensing Surgical Gloves","NOT_YET_RECRUITING","2026-05-05",{"date":30,"type":31},"2026-05-06","ACTUAL",{"date":33,"type":19},"2026-07",{"date":35,"type":19},"2026-11",{"name":37,"class":38},"NHS Lothian","OTHER_GOV",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":46,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":20,"phases":51,"briefSummary":52,"conditions":53,"keywords":62,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":39},"100633435","head-cooling-in-ischaemic-stroke-patients-undergoing-endovascular-thrombectomy-coolhead-2b-100633435","NCT07526649","Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy (COOLHEAD-2b)","Head Cooling in Ischaemic Stroke Patients Undergoing Endovascular Thrombectomy: A Phase 2 Randomised Controlled Trial (COOLHEAD-2b)","COOLHEAD-2B","Inclusion Criteria:\n\n* Acute anterior circulation ischaemic stroke planned for endovascular thrombectomy\n* Age ≥18 years\n\nExclusion Criteria:\n\n* Pre-stroke modified Rankin Scale score \\>2\n* Core body temperature \\\u003C35°C at admission\n* Uncontrolled hypertension (≥185\u002F110 mmHg despite treatment in IVT-eligible patients)\n* Known contraindications to hypothermia (e.g., haemodynamic instability, symptomatic bradyarrhythmia, cryoglobulinaemia, sickle cell disease, cold agglutinins)\n* Vasospastic disorders (e.g., Raynaud's phenomenon)\n* Skin lesions preventing secure application of the cooling cap\n* Inability to participate in 90-day follow-up","18 Years",{"count":50,"type":19},182,[22],"COOLHEAD-2b is a multicentre, phase 2, prospective, randomised, controlled, open-label, blinded-endpoint trial evaluating the safety and efficacy of non-invasive convective head cooling as an adjunct to endovascular thrombectomy (EVT) in patients with acute anterior circulation ischaemic stroke. Head cooling is initiated as early as possible, including during inter-hospital transfer, and continued until one hour after reperfusion. The primary efficacy endpoint is final infarct volume at 24 hours.",[54,55,56,57,58,25,59,60,61],"Stroke","Acute Ischemic Stroke","Brain Ischemia","Ischaemic Stroke","Thrombectomy","Reperfusion Injury","Cooling","Large Vessel Occlusion",[63,64,65,66,67,68],"Head cooling","Selective brain cooling","Endovascular thrombectomy","Therapeutic hypothermia","Penumbra","Neuroprotection","2026-04-09",{"date":71,"type":31},"2026-04-13",{"date":73,"type":19},"2026-04-10",{"date":75,"type":19},"2029-06-30",{"name":77,"class":38},"Auckland City Hospital",{"id":79,"slug":80,"hasResults":11,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":4,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":85,"targetDuration":4,"studyType":87,"phases":4,"briefSummary":88,"conditions":89,"keywords":4,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":39},"100428072","introduction-of-an-operating-room-black-box-to-identify-analyse-and-prevent-errors-in-the-vascular-hybrid-room-100428072","NCT04854278","Introduction of an Operating Room Black Box to Identify, Analyse and Prevent Errors in the Vascular Hybrid Room","Development of Strategies to Identify, Analyse and Prevent Errors in the Vascular Hybrid Room - an Inter-professional Approach to Enhance Technical and Non-technical Performance and to Improve Patient Safety","Inclusion Criteria:\n\n* Patients undergoing elective (planned more than 48 hours) endovascular procedures.\n* Symptomatic aortic-iliac-femoral-popliteal-below the knee atherosclerotic stenotic or occlusive disease (PVI)\n* Endovascular exclusion of thoracic aortic, infrarenal abdominal aortic and\u002For iliac aneurysm repair (EVAR)\n\nExclusion Criteria:\n\n* No consent of patient\n* No consent of all endovascular team members\n* Emergency procedure (planned \\\u003C 48h before)\n* Endovascular procedure not treating atherosclerotic aortic-iliac-femoral-popliteal-below the knee disease or aortic-iliac aneurysm",{"count":86,"type":19},400,"OBSERVATIONAL","The \"OR Black box\", an inclusive multiport data capturing system has been developed and successfully used for detailed analysis of laparoscopic surgical procedures. A pilot study has shown that this system can be successfully installed in the hybrid room at Ghent University Hospital and used for detailed analysis of intra-operative errors and radiation safety issues in endovascular procedures.\n\nSecondary analysis of pilot study data via direct video coding assessed the relationship between leadership style of the surgeon and team behavior and possible fluctuations during surgery.\n\nThis novel approach allows a prospective objective assessment of human and environmental factors as well as measurement of errors, events and outcomes. In this study, the aim is to use the acquired knowledge to characterize a chain of events, identify high-risk interventions and identify areas for improvement, both on an organizational, team or individual level.\n\nHypothesis: non-technical skills, environmental factors and teamwork in the hybrid room correlate with surgical technical performance and error rates. Furthermore, we hypothesize that incidents and adverse events can be tracked to a chain of errors that is influenced by technical and non-technical skills as well as environmental factors.",[90,25,91],"Patient Safety","Quality Improvement","RECRUITING","2025-12-15",{"date":95,"type":31},"2025-12-22",{"date":97,"type":31},"2019-02-19",{"date":99,"type":19},"2027-12-31",{"name":101,"class":102},"University Ghent","OTHER",{"id":104,"slug":105,"hasResults":11,"nctId":106,"briefTitle":107,"officialTitle":107,"acronym":108,"eligibilityCriteria":109,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":110,"targetDuration":4,"studyType":87,"phases":4,"briefSummary":112,"conditions":113,"keywords":118,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":126,"lastUpdatePostDateStruct":127,"startDateStruct":129,"completionDateStruct":131,"leadSponsor":133,"locationsCount":5},"100504719","study-on-prognosis-of-acutely-ruptured-intracranial-aneurysms-100504719","NCT05851989","Study on Prognosis of Acutely Ruptured Intracranial Aneurysms","SPARTA","Inclusion Criteria:\n\n* Confirmed diagnosis of subarachnoid haemorrhage on CT-scan or lumbar puncture (in the presence of a negative CT-scan)\n* Intracranial aneurysm proven within 6 months to be the cause of subarachnoid haemorrhage\n* Age 18 years or over at presentation.\n* Written informed consent\n\nExclusion Criteria:\n\n* Subarachnoid haemorrhage deemed most likely of 'perimesencephalic' origin after consideration of history, clinical examination and radiological findings (including angiographic imaging)\n* Subarachnoid haemorrhage deemed most likely of post-traumatic origin after consideration of history, clinical examination and radiological findings (including angiographic imaging)\n* Diagnosis of intracerebral arteriovenous malformations or dural arteriovenous fistula.\n* No diagnosis of intracranial aneurysm at 6 months after onset of symptoms.\n* Not mastering the Dutch language",{"count":111,"type":19},880,"The SPARTA study is a prospective multicenter observational trial in the Netherlands with the aim of identifying the best clinical care in patients with aneurysmal subarachnoidal haemorrhage. Differences in outcome between surgical treatment and endovascular treatment will be explored.\n\nFurthermore, cost effectiveness and radiological prognostic factors will be examined.",[114,25,115,116,117],"Aneurysmal Subarachnoid Hemorrhage","Craniotomy","Patient Outcome Assessment","Treatment Outcome",[119,120,121,122,123,124,125],"Aneurysmal subarachnoid hemorrhage","Clipping","Neurosurgery","Coiling","Endovascular treatment","Outcome","Modified Rankin Scale","2025-03-22",{"date":128,"type":31},"2025-03-25",{"date":130,"type":31},"2021-07-14",{"date":132,"type":19},"2034-07-14",{"name":134,"class":102},"Haaglanden Medical Centre",{"id":136,"slug":137,"hasResults":11,"nctId":138,"briefTitle":139,"officialTitle":140,"acronym":141,"eligibilityCriteria":142,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":143,"targetDuration":145,"studyType":87,"phases":4,"briefSummary":146,"conditions":147,"keywords":149,"overallStatus":92,"whyStopped":4,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":154,"completionDateStruct":156,"leadSponsor":158,"locationsCount":160},"100489902","triage-of-patients-with-acute-ischemic-stroke-due-to-large-vessel-occlusions-2-100489902","NCT05659160","Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2","Triage of Patients With Acute Ischemic Stroke Due to Large Vessel Occlusions-2 (TRACK-LVO-2): an Imaging-based Patient Registry Study","TRACK-LVO-2","Inclusion Criteria:\n\n1. Patient admitted from Jan. 1st 2018 to Jan. 1st 2028;\n2. Age ≥ 18;\n3. Ischemic stroke confirmed by head CT or MRI;\n4. Large vessel occlusion confirmed by head CTA or MRA: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1\u002FM2), anterior cerebral artery (ACA A1\u002FA2), basilar artery (BA), vertebral artery (VA), and posterior cerebral artery (PCA P1\u002FP2);\n5. Patients receiving either endovascular therapy or best medical treatment;\n\nExclusion Criteria:\n\n\\- None",{"count":144,"type":19},5000,"1 Year","The objective of this study is to create a comprehensive, real-world, multi-center observational registry of consecutive patients admitted to hospitals with acute ischemic stroke (AIS) caused by large vessel occlusions (LVO), who are treated with either endovascular therapy (EVT) or the best available medical management (BMM).",[148,25,61],"Stroke, Acute Ischemic",[55,150,61],"Endovascular Therapy","2023-11-28",{"date":153,"type":31},"2023-12-01",{"date":155,"type":31},"2021-11-01",{"date":157,"type":19},"2028-12-31",{"name":159,"class":102},"Tianjin Huanhu Hospital",4,{"id":162,"slug":163,"hasResults":11,"nctId":164,"briefTitle":165,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":16,"minAge":48,"maxAge":4,"enrollmentInfo":168,"targetDuration":170,"studyType":87,"phases":4,"briefSummary":171,"conditions":172,"keywords":175,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":182,"completionDateStruct":184,"leadSponsor":186,"locationsCount":39},"100489468","remote-ischemic-conditioning-combined-with-endovascular-stenting-for-symptomatic-intracranial-atherosclerotic-stenosis-100489468","NCT05653505","Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic Stenosis","Safety and Efficacy of Remote Ischemic Conditioning Combined With Endovascular Stenting in Patients With Symptomatic Intracranial Atherosclerotic Stenosis","Inclusion Criteria:\n\n1. Patient admitted from Jan. 1st 2023 to Jan. 1st 2025;\n2. Age ≥ 18;\n3. Intracranial atherosclerosis stenosis measured as ≥70% by digital subtraction angiography or by other noninvasive methods, such as transcranial doppler, computed tomography angiography, or magnetic resonance angiography;\n4. A history of stroke\u002Ftransient ischemic attack attributed to ICAS;\n5. Verbal and written informed consent is provided at the time of admission by patients or their legally authorized representatives.\n\nExclusion Criteria:\n\n1. Stenosis of other causes;\n2. Prior ipsilateral stroke with residual deficits;\n3. Uncontrolled hypertension (defined as systolic blood pressure ≥200 mm Hg despite medications at enrollment);\n4. Peripheral vascular disease (especially subclavian arterial and upper limb artery stenosis or occlusion).",{"count":169,"type":19},160,"12 Months","The purpose of this registry is to evaluate the safety and efficacy of RIC for patients with symptomatic intracranial atherosclerotic stenosis (sICAS) undergoing endovascular therapy.",[173,174,25],"Intracranial Arteriosclerosis","Ischemic Preconditioning",[176,177,178],"Remote Ischemic Conditioning","Endovascular Stenting","Symptomatic Intracranial Atherosclerotic Stenosis","2022-12-15",{"date":181,"type":31},"2022-12-16",{"date":183,"type":19},"2023-01-01",{"date":185,"type":19},"2026-07-01",{"name":159,"class":102}]